Exome sequencing and digital PCR analyses reveal novel mutated genes related to the metastasis of pancreatic ductal adenocarcinoma

References

• Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. in CA Cancer J Clin, Vol. 60 277-300 (2010 American Cancer Society, Inc., United States, 2010).
   Google Scholar
• Bayraktar S, Rocha-Lima CM. Advanced or metastatic pancreatic cancer: molecular targeted therapies. Mt Sinai J Med 2010; 77:606 - 19; http://dx.doi.org/10.1002/msj.20217; PMID: 21105124
   PubMed Web of Science ®Google Scholar
• Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010; 467:1114 - 7; http://dx.doi.org/10.1038/nature09515; PMID: 20981102
   PubMed Web of Science ®Google Scholar
• Campbell PJ, Yachida S, Mudie LJ, Stephens PJ, Pleasance ED, Stebbings LA, et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 2010; 467:1109 - 13; http://dx.doi.org/10.1038/nature09460; PMID: 20981101
   PubMed Web of Science ®Google Scholar
• Wang K, Li M, Hadley D, Liu R, Glessner J, Grant SF, et al. PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res 2007; 17:1665 - 74; http://dx.doi.org/10.1101/gr.6861907; PMID: 17921354
   PubMed Web of Science ®Google Scholar
• Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008; 321:1801 - 6; http://dx.doi.org/10.1126/science.1164368; PMID: 18772397
   PubMed Web of Science ®Google Scholar
• Berrozpe G, Schaeffer J, Peinado MA, Real FX, Perucho M. Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer. Int J Cancer 1994; 58:185 - 91; http://dx.doi.org/10.1002/ijc.2910580207; PMID: 8026879
   PubMed Web of Science ®Google Scholar
• Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, et al. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 1994; 8:27 - 32; http://dx.doi.org/10.1038/ng0994-27; PMID: 7726912
   PubMed Web of Science ®Google Scholar
• Kim DH, Crawford B, Ziegler J, Beattie MS. Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations. Fam Cancer 2009; 8:153 - 8; http://dx.doi.org/10.1007/s10689-008-9220-x; PMID: 18855126
   PubMed Web of Science ®Google Scholar
• Horii A, Nakatsuru S, Miyoshi Y, Ichii S, Nagase H, Ando H, et al. Frequent somatic mutations of the APC gene in human pancreatic cancer. Cancer Res 1992; 52:6696 - 8; PMID: 1423316
   PubMed Web of Science ®Google Scholar
• Geoffroy-Perez B, Janin N, Ossian K, Laugé A, Croquette MF, Griscelli C, et al. Cancer risk in heterozygotes for ataxia-telangiectasia. Int J Cancer 2001; 93:288 - 93; http://dx.doi.org/10.1002/ijc.1329; PMID: 11410879
   PubMed Web of Science ®Google Scholar
• Reddy KB, Nabha SM, Atanaskova N. Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev 2003; 22:395 - 403; http://dx.doi.org/10.1023/A:1023781114568; PMID: 12884914
   PubMed Web of Science ®Google Scholar
• Wolfer A, Ramaswamy S. MYC and metastasis. Cancer Res 2011; 71:2034 - 7; http://dx.doi.org/10.1158/0008-5472.CAN-10-3776; PMID: 21406394
   PubMed Web of Science ®Google Scholar
• Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006; 441:431 - 6; http://dx.doi.org/10.1038/nature04870; PMID: 16724054
   PubMed Web of Science ®Google Scholar
• Hirata H, Hinoda Y, Nakajima K, Kawamoto K, Kikuno N, Kawakami K, et al. Wnt antagonist gene DKK2 is epigenetically silenced and inhibits renal cancer progression through apoptotic and cell cycle pathways. Clin Cancer Res 2009; 15:5678 - 87; http://dx.doi.org/10.1158/1078-0432.CCR-09-0558; PMID: 19755393
   PubMed Web of Science ®Google Scholar
• Armengol G, Capellà G, Farré L, Peinado MA, Miró R, Caballín MR. Genetic evolution in the metastatic progression of human pancreatic cancer studied by CGH. Lab Invest 2001; 81:1703 - 7; http://dx.doi.org/10.1038/labinvest.3780383; PMID: 11742040
   PubMed Web of Science ®Google Scholar
• Morton JP, Timpson P, Karim SA, Ridgway RA, Athineos D, Doyle B, et al. Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer. Proc Natl Acad Sci U S A 2010; 107:246 - 51; http://dx.doi.org/10.1073/pnas.0908428107; PMID: 20018721
   PubMed Web of Science ®Google Scholar
• Schulz P, Scholz A, Rexin A, Hauff P, Schirner M, Wiedenmann B, et al. Inducible re-expression of p16 in an orthotopic mouse model of pancreatic cancer inhibits lymphangiogenesis and lymphatic metastasis. Br J Cancer 2008; 99:110 - 7; http://dx.doi.org/10.1038/sj.bjc.6604457; PMID: 18577984
   PubMed Web of Science ®Google Scholar
• Iacobuzio-Donahue CA, Fu B, Yachida S, Luo M, Abe H, Henderson CM, et al. DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol 2009; 27:1806 - 13; http://dx.doi.org/10.1200/JCO.2008.17.7188; PMID: 19273710
   PubMed Web of Science ®Google Scholar
• James E, Waldron-Lynch MG, Saif MW. Prolonged survival in a patient with BRCA2 associated metastatic pancreatic cancer after exposure to camptothecin: a case report and review of literature. Anticancer Drugs 2009; 20:634 - 8; http://dx.doi.org/10.1097/CAD.0b013e32832b511e; PMID: 19433978
   PubMed Web of Science ®Google Scholar
• Chalasani P, Kurtin S, Dragovich T. Response to a third-line mitomycin C (MMC)-based chemotherapy in a patient with metastatic pancreatic adenocarcinoma carrying germline BRCA2 mutation. JOP 2008; 9:305 - 8; PMID: 18469443
   PubMedGoogle Scholar
• Collisson EA, Sadanandam A, Olson P, Gibb WJ, Truitt M, Gu S, et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat Med 2011; 17:500 - 3; http://dx.doi.org/10.1038/nm.2344; PMID: 21460848
   PubMed Web of Science ®Google Scholar
• Strimpakos AS, Syrigos KN, Saif MW. The molecular targets for the diagnosis and treatment of pancreatic cancer. Gut Liver 2010; 4:433 - 49; http://dx.doi.org/10.5009/gnl.2010.4.4.433; PMID: 21253292
   PubMed Web of Science ®Google Scholar
• Jones SJ, Laskin J, Li YY, Griffith OL, An J, Bilenky M, et al. Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors. Genome Biol 2010; 11:R82; http://dx.doi.org/10.1186/gb-2010-11-8-r82; PMID: 20696054
   PubMed Web of Science ®Google Scholar
• Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25:1754 - 60; http://dx.doi.org/10.1093/bioinformatics/btp324; PMID: 19451168
   PubMed Web of Science ®Google Scholar
• Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol 2011; 29:24 - 6; http://dx.doi.org/10.1038/nbt.1754; PMID: 21221095
   PubMed Web of Science ®Google Scholar
• Goya R, Sun MG, Morin RD, Leung G, Ha G, Wiegand KC, et al. SNVMix: predicting single nucleotide variants from next-generation sequencing of tumors. Bioinformatics 2010; 26:730 - 6; http://dx.doi.org/10.1093/bioinformatics/btq040; PMID: 20130035
   PubMed Web of Science ®Google Scholar
• Shah SP, Morin RD, Khattra J, Prentice L, Pugh T, Burleigh A, et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 2009; 461:809 - 13; http://dx.doi.org/10.1038/nature08489; PMID: 19812674
   PubMed Web of Science ®Google Scholar
• Lieber M, Mazzetta J, Nelson-Rees W, Kaplan M, Todaro G. Establishment of a continuous tumor-cell line (panc-1) from a human carcinoma of the exocrine pancreas. Int J Cancer 1975; 15:741 - 7; http://dx.doi.org/10.1002/ijc.2910150505; PMID: 1140870
   PubMed Web of Science ®Google Scholar
• Okabe T, Yamaguchi N, Ohsawa N. Establishment and characterization of a carcinoembryonic antigen (CEA)-producing cell line from a human carcinoma of the exocrine pancreas. Cancer 1983; 51:662 - 8; http://dx.doi.org/10.1002/1097-0142(19830215)51:4<662::AID-CNCR2820510419>3.0.CO;2-X; PMID: 6821838
   PubMed Web of Science ®Google Scholar
• Chen WH, Horoszewicz JS, Leong SS, Shimano T, Penetrante R, Sanders WH, et al. Human pancreatic adenocarcinoma: in vitro and in vivo morphology of a new tumor line established from ascites. In Vitro 1982; 18:24 - 34; http://dx.doi.org/10.1007/BF02796382; PMID: 7182348
   PubMedGoogle Scholar
• Tan MH, Nowak NJ, Loor R, Ochi H, Sandberg AA, Lopez C, et al. Characterization of a new primary human pancreatic tumor line. Cancer Invest 1986; 4:15 - 23; http://dx.doi.org/10.3109/07357908609039823; PMID: 3754176
   PubMed Web of Science ®Google Scholar
• Kyriazis AP, McCombs WB 3rd, Sandberg AA, Kyriazis AA, Sloane NH, Lepera R. Establishment and characterization of human pancreatic adenocarcinoma cell line SW-1990 in tissue culture and the nude mouse. Cancer Res 1983; 43:4393 - 401; PMID: 6871872
   PubMed Web of Science ®Google Scholar